Somatostatin analogs for the treatment of neuroendocrine tumors

By Culler Michael   Öberg Kjell   Arnold Rudolf   Krenning Eric   Sevilla Isabel   Díaz José  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of endocrine pancreatic tumors

By Fjällskog Marie-Louise   Janson Eva Tiensuu  

Acta Oncologica, Vol. 44, Iss. 4, 2005-06 ,pp. : 329-338

Informa Healthcare

Access to resources Recommend Favorite

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

By Fjällskog Marie-Louise   Ludvigsen Eva   Stridsberg Mats   Öberg Kjell   Eriksson Barbro   Janson Eva  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 59-67

Humana Press, Inc

Access to resources Recommend Favorite

Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors

By Kaubisch Andreas   Kaleya Ron   Haynes Hilda   Rozenblit Alla   Wadler Scott  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 337-340

Springer Publishing Company

Access to resources Recommend Favorite

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 237-254

Bentham Science Publishers

Access to resources Recommend Favorite